0001567619-21-013914.txt : 20210723 0001567619-21-013914.hdr.sgml : 20210723 20210723183939 ACCESSION NUMBER: 0001567619-21-013914 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210721 FILED AS OF DATE: 20210723 DATE AS OF CHANGE: 20210723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSENZWEIG RICHARD C CENTRAL INDEX KEY: 0001206725 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 211111905 MAIL ADDRESS: STREET 1: C/O ANGIODYNAMICS INC. STREET 2: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 4 1 doc1.xml FORM 4 X0306 4 2021-07-21 0 0001275187 ANGIODYNAMICS INC ANGO 0001206725 ROSENZWEIG RICHARD C 14 PLAZA DRIVE LATHAM NY 12110 0 1 0 0 SVP and General Counsel Common Stock 2021-07-21 4 A 0 3098 0 A 14098 D Performance Right 2021-07-21 4 A 0 6197 0 A Common Stock 6197 6197 D Non-Qualified Stock Option (right to buy) 10.27 2021-07-21 4 A 0 8418 0 A 2022-07-21 2031-07-21 Common Stock 8418 8418 D The acquisition of 3,098 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company") represents 3,098 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 21, 2022, such that 25% of the restricted stock units will vest on each of July 21, 2022, 2023, 2024 and 2025. Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025. /s/ Richard C. Rosenzweig 2021-07-23